FDA.reportPublic FDA data

Simbrinza (brimonidine tartrate 0.2 % / brinzolamide 1 % ) Ophthalmic Suspension

RxCUI
1421456
RxNorm name
Simbrinza (brimonidine tartrate 0.2 % / brinzolamide 1 % ) Ophthalmic Suspension
Display name
Simbrinza (brimonidine tartrate 0.2 % / brinzolamide 1 % ) Ophthalmic Suspension
Full name
Simbrinza (brimonidine tartrate 0.2 % / brinzolamide 1 % ) Ophthalmic Suspension
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:12

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
SIMBRINZABRINZOLAMIDE/BRIMONIDINE TARTRATEAlcon Laboratories, Inc.a49c157e-6310-0011-7b7f-e26fc1820d592025-03-11Warnings, Adverse reactionsExact identifier
rxcui: 1421456

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
a49c157e-6310-0011-7b7f-e26fc1820d59Simbrinza (brimonidine tartrate 0.2 % / brinzolamide 1 % ) Ophthalmic SuspensionSY19These highlights do not include all the information needed to use SIMBRINZA ® safely and effectively. See full prescribing information for SIMBRINZA. SIMBRINZA ® (brinzolamide and brimonidine tartrate ophthalmic suspension) 1%/0.2%, for topical ophthalmic use Initial U.S. Approval: 201320250311
a49c157e-6310-0011-7b7f-e26fc1820d59brimonidine tartrate 2 MG/ML / brinzolamide 10 MG/ML Ophthalmic Suspension [Simbrinza]SBD19These highlights do not include all the information needed to use SIMBRINZA ® safely and effectively. See full prescribing information for SIMBRINZA. SIMBRINZA ® (brinzolamide and brimonidine tartrate ophthalmic suspension) 1%/0.2%, for topical ophthalmic use Initial U.S. Approval: 201320250311
a49c157e-6310-0011-7b7f-e26fc1820d59SIMBRINZA 1 % / 0.2 % Ophthalmic SuspensionPSN19These highlights do not include all the information needed to use SIMBRINZA ® safely and effectively. See full prescribing information for SIMBRINZA. SIMBRINZA ® (brinzolamide and brimonidine tartrate ophthalmic suspension) 1%/0.2%, for topical ophthalmic use Initial U.S. Approval: 201320250311